Menu Search
Equities

YSB Inc

9885:HKG.HS

YSB Inc

Actions
  • Price (HKD)7.88
  • Today's Change0.40 / 5.35%
  • Shares traded641.60k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

YSB Inc is an investment holding company mainly engaged in the provision of wholesale and retail of pharmaceuticals and healthcare products, as well as the provision of platform business services. The Company is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The Company provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The Company also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The Company principally conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)18.35bn
  • Net income in HKD-3.45bn
  • Incorporated2015
  • Employees6.31k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.